CM Management, LLC
CM Management, LLC is an exempt reporting adviser that reports managing 1 hedge fund on Form ADV. Its private funds, of all types, hold $126.0 million in gross assets. Its disclosed U.S. stock holdings returned an estimated +29.9% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +73.2% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.
- Regulatory assets under management
- —Form ADV Item 5.F
- Gross assets of private funds
- $126.0 millionAll private fund types, Form ADV
- Hedge funds managed
- 11 private funds in total
- Employees
- —Form ADV Item 5.A
- Registration
- Exempt reporting adviserCRD 162198
- Latest Form ADV
- 03/18/2026Disciplinary disclosures: none reported
Estimated 13F portfolio performance
| Quarter | Est. 13F return | S&P 500 |
|---|---|---|
| Q2 2026 | +23.7% | +14.8% |
| Q1 2026 | +5.1% | -4.6% |
| Q4 2025 | +7.8% | +2.4% |
| Q3 2025 | +16.9% | +7.8% |
| Q2 2025 | +3.5% | +10.4% |
| Q1 2025 | -4.0% | -4.5% |
| Q4 2024 | -3.4% | +2.1% |
| Q3 2024 | +10.1% | +5.4% |
Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures
Largest disclosed holdings
- Rigel Pharmaceuticals Inc$9.8 million
- Alico Inc$8.3 million
- Royalty Pharma PLC$7.0 million
- Radiant Logistics Inc$5.9 million
- BGC Group Inc$4.8 million
- Everest Group LTD$4.5 million
- Marinemax Inc$4.0 million
- Copa Holdings SA F Class A$3.7 million
- Organon & Co.$3.7 million
- Columbus Mckinnon Corp N Y$3.0 million
As of 2026-06-30, from 13F filing by CM Management, LLC.
From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. HedgeMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures